Zhejiang Dayang Biology Technology Co.,Ltd. (003017.SZ)
CNY 20.22
(-0.64%)
CNY 20.22
(-0.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 182.42 Million | 91.88 Million | -35.15 Million | 112.48 Million | 113.09 Million | 38.77 Million |
| Net Income | 50 Million | 80.72 Million | 70 Million | 91.6 Million | 79.49 Million | 70.79 Million |
| Depreciation & Amortization | 69.67 Million | 60.25 Million | 45.09 Million | 31.3 Million | 29.98 Million | 25.8 Million |
| Deferred income taxes | -3.72 Million | -23.31 Million | 5.74 Million | 1.79 Million | 3.38 Million | 3.56 Million |
| Stock-based compensation | 7.26 Million | 11.95 Million | - | - | - | - |
| Change in working capital | 33.85 Million | -49.56 Million | -144.52 Million | -12.49 Million | 1.12 Million | -66.45 Million |
| Other non-cash items | 6.26 Million | 11.82 Million | -5.74 Million | 2.07 Million | 2.48 Million | 8.63 Million |
| Investing Cash Flow | 145.08 Million | -109.88 Million | 8.89 Million | -492.98 Million | -61.67 Million | -27.14 Million |
| Investments in PPE | -103.62 Million | -104.65 Million | -93.43 Million | -124.82 Million | -61.84 Million | -44.05 Million |
| Acquisitions | 1.36 Million | 6.84 Million | 724.01 Thousand | 306.81 Thousand | 631.56 Thousand | 5.98 Million |
| Investment purchases | -288.1 Million | -1.03 Billion | -1.06 Billion | -597.1 Million | -631.56 Thousand | - |
| Sales/Maturities of investments | 535.45 Million | 1.02 Billion | 1.16 Billion | 229.23 Million | 695.03 Thousand | 393.78 Thousand |
| Other Investing Activities | 1.36 Million | 0.07 | 613.12 Thousand | -599.99 Thousand | -529.67 Thousand | 10.53 Million |
| Financing Cash Flow | -75.67 Million | 16.87 Million | 89.39 Million | 396.36 Million | -27.61 Million | -23.47 Million |
| Debt repayment | -32.12 Million | -453.94 Million | -10.06 Million | -28 Million | -53 Million | -98.5 Million |
| Dividends payments | -34.99 Million | -34.32 Million | -36 Million | -13.5 Million | -23.96 Million | -23.4 Million |
| Common Stock Repurchased | - | -88.09 Million | - | 49.18 Million | - | - |
| Common Stock Issuance | - | 88.09 Million | - | -49.18 Million | - | - |
| Other Financing Activities | -943.3 Thousand | 509.87 Million | 137.76 Million | 438.43 Million | 49.34 Million | 98.42 Million |
| Accounts receivables | 5.98 Million | -65.95 Million | -40.68 Million | -94.86 Million | 11.29 Million | -71.1 Million |
| Accounts payables | 59.86 Million | 5.15 Million | -16.31 Million | 68.08 Million | -12.47 Million | 25.18 Million |
| Inventory | -28.27 Million | 34.55 Million | -93.25 Million | 12.48 Million | -1.08 Million | -24.1 Million |
| Other working capital | 7.26 Million | -23.31 Million | 5.74 Million | 1.79 Million | 3.38 Million | -42.35 Million |
| Cash at beginning of period | 129.79 Million | 131.88 Million | 68.75 Million | 53.11 Million | 29.37 Million | 41.21 Million |
| Cash at end of period | 381.52 Million | 129.79 Million | 131.88 Million | 68.75 Million | 53.11 Million | 29.37 Million |
| Capital Expenditure | -103.62 Million | -104.65 Million | -93.43 Million | -124.82 Million | -61.84 Million | -44.05 Million |
| Effect of forex changes on cash | -101.35 Thousand | -964.46 Thousand | -3779.30 | -237.72 Thousand | -58.21 Thousand | 18.5 Thousand |
| Net cash flow / Change in cash | 251.73 Million | -2.08 Million | 63.12 Million | 15.63 Million | 23.74 Million | -11.83 Million |
| Free Cash Flow | 78.79 Million | -12.76 Million | -128.58 Million | -12.33 Million | 51.25 Million | -5.27 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 19.82 Million | 14.51 Million | 16.91 Million | 9.83 Million | 50 Million | 16.31 Million |
| Depreciation & Amortization | - | 16.75 Million | 16.75 Million | 16.77 Million | 69.67 Million | 16.77 Million |
| Deferred income taxes | - | -1.97 Million | - | - | -3.72 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | 33.85 Million | - |
| Other non-cash items | -9546.73 | 38.55 Million | -16.55 Million | 119.04 Million | 6.26 Million | 11.28 Million |
| Investing Cash Flow | -73.85 Million | -56.2 Million | -26.55 Million | -67.23 Million | 145.08 Million | 102.68 Million |
| Investments in PPE | 3.03 Million | -21.37 Million | -27.24 Million | -49.81 Million | -103.62 Million | -6.06 Million |
| Acquisitions | 90 Thousand | 1.17 Million | 510 Thousand | 413.86 Thousand | 1.36 Million | 570.55 Thousand |
| Investment purchases | -108 Million | -45 Million | - | 46.41 Million | -288.1 Million | -162.81 Million |
| Sales/Maturities of investments | 31.01 Million | 9 Million | 182.86 Thousand | -64.25 Million | 535.45 Million | 270.99 Million |
| Other Investing Activities | 90 Thousand | - | - | - | - | 0.22 |
| Financing Cash Flow | -6.16 Million | 91.18 Million | -55.74 Million | -128.08 Million | -75.67 Million | -8.36 Million |
| Debt repayment | -29.46 Million | -76.2 Million | -16.23 Million | -100.25 Million | -32.12 Million | -129.11 Million |
| Dividends payments | -41.07 Million | -1.53 Million | -2.51 Million | -26.88 Million | -34.99 Million | -1.19 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 5.44 Million | 56.18 Million | -37 Million | 8.1 Million | -943.3 Thousand | 121.95 Million |
| Accounts receivables | - | - | - | - | 5.98 Million | - |
| Accounts payables | - | - | - | - | 59.86 Million | - |
| Inventory | - | - | - | - | -28.27 Million | - |
| Other working capital | - | - | - | - | 7.26 Million | - |
| Cash at beginning of period | 369.56 Million | 300.69 Million | 381.52 Million | 466.84 Million | 129.79 Million | 344.97 Million |
| Cash at end of period | 308.98 Million | 372.26 Million | 299.85 Million | 381.52 Million | 381.52 Million | 466.84 Million |
| Capital Expenditure | 3.03 Million | -21.37 Million | -27.24 Million | -49.81 Million | -103.62 Million | -6.06 Million |
| Effect of forex changes on cash | -369.7 Thousand | 391.63 Thousand | 456.51 Thousand | -395.64 Thousand | -101.35 Thousand | -52.51 Thousand |
| Net cash flow / Change in cash | -60.58 Million | 71.56 Million | -81.67 Million | -85.31 Million | 251.73 Million | 121.86 Million |
| Free Cash Flow | 22.85 Million | 12.96 Million | -26.89 Million | 62.28 Million | 78.79 Million | 21.53 Million |
MNTR
SCIA
REI
GLFGF
SASY
VISIONCINE